GlassScriptPhysician profile
Farnaz Almasganj
NPI 1568672160
$9,218.66
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.05 · 2021: $32.02 · 2022: $8,538 · 2023: $620 · 2024: $18.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $638.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $637.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,519.34 | 2022 | |
| Abbvie INC. | $331.67 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Hologic Sales and Service, LLC | $218.06 | 2022-2024 | Coolseal Generator, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $183.32 | 2022-2023 | |
| Organon LLC | $167.37 | 2022-2023 | Nexplanon |
| Merck Sharp & Dohme LLC | $110.39 | 2022-2023 | Gardasil 9 |
| Aspira Women'S Health INC | $99.77 | 2022 | |
| Myovant Sciences INC. | $68.70 | 2022 | |
| Agile Therapeutics, INC. | $54.76 | 2021-2023 | Twirla |
| Pfizer INC. | $52.38 | 2022-2023 | |
| Therapeuticsmd, INC. | $50.15 | 2021-2022 | |
| Mylan Pharmaceuticals INC. | $43.39 | 2022 | |
| Amgen INC. | $40.66 | 2023 | Evenity, Prolia |
| Shield Therapeutics INC | $38.93 | 2023 | Accrufer |
| Exact Sciences Corporation | $32.42 | 2023 | Cologuard Collection Kit |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $31.80 | 2023 | Myfembree |
| Alexion Pharmaceuticals, INC. | $31.66 | 2023 | Ultomiris |
| Exeltis, USA INC. | $27.03 | 2023 | Slynd |
| Evofem Biosciences, INC. | $26.50 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $22.06 | 2022 | |
| Ethicon US, LLC | $18.99 | 2023 | Stratafix |
| Coopersurgical, INC. | $17.72 | 2023 | Paragard T 380a |
| Avion Pharmaceuticals | $16.31 | 2023 | Balcoltra |
| Scynexis, INC. | $15.28 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Farnaz Almasganj listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.